Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP46229.RADm1Q_vsssRbdLYvnNfaCIi1RXisMi75X0KLTQGDzlxw130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46229.RADm1Q_vsssRbdLYvnNfaCIi1RXisMi75X0KLTQGDzlxw130_provenance.
• NP48026.RA_zdvGquUbHs-dUvHXSHUrc1TKctiwWN86vpVvkKsnSc130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP48026.RA_zdvGquUbHs-dUvHXSHUrc1TKctiwWN86vpVvkKsnSc130_provenance.
• NP55486.RA_ATIYQxmY6adSSyvHjJcWY-yyqa4OOvGY5HK0sVXnWE130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55486.RA_ATIYQxmY6adSSyvHjJcWY-yyqa4OOvGY5HK0sVXnWE130_provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP230629.RAw1Ws-RX1KY0C4FY7u5UrSmTM64FAuJdzVG8flpdqXYE130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230629.RAw1Ws-RX1KY0C4FY7u5UrSmTM64FAuJdzVG8flpdqXYE130_provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP63431.RAvof7W9GmPkRPflKljcWufKq2dOV32Zk5_t03WviN1fw130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63431.RAvof7W9GmPkRPflKljcWufKq2dOV32Zk5_t03WviN1fw130_provenance.
• NP703222.RANTaVEU7kkwqYJQadodDbwPjmV_68733O3wymRr3X1Y8130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703222.RANTaVEU7kkwqYJQadodDbwPjmV_68733O3wymRr3X1Y8130_provenance.
• NP123335.RABVqYAPSiGhNbyxSEaFgZnQ7ZxcVPvB_6wv6WBpKS3pA130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123335.RABVqYAPSiGhNbyxSEaFgZnQ7ZxcVPvB_6wv6WBpKS3pA130_provenance.
• NP672238.RATwrLZ_S4IXaS3Bq0j99Fvb5dUhJidLOFq0xcysOuR0A130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672238.RATwrLZ_S4IXaS3Bq0j99Fvb5dUhJidLOFq0xcysOuR0A130_provenance.
• NP712435.RAma5UnH80i0PtJr60k-bNyVxpAd3DZdz9iBXMpqZGVyg130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712435.RAma5UnH80i0PtJr60k-bNyVxpAd3DZdz9iBXMpqZGVyg130_provenance.
• NP55629.RAIUzVK30X_8Cur2mxsZLlnvy4iJm5Tfq40fyySMUfunU130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55629.RAIUzVK30X_8Cur2mxsZLlnvy4iJm5Tfq40fyySMUfunU130_provenance.
• NP868866.RAGnvT84eHPAJEZOwqlMzDfAER8W19tLh7IHuEF9eJEU8130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868866.RAGnvT84eHPAJEZOwqlMzDfAER8W19tLh7IHuEF9eJEU8130_provenance.
• NP672239.RAt4866FZTF1myhZmrFQL9JO1fBmh2qtKOzX-PF4vOI9c130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672239.RAt4866FZTF1myhZmrFQL9JO1fBmh2qtKOzX-PF4vOI9c130_provenance.
• NP672245.RAqtgG_BWevzynJxMnyrQ_Ckpc4hYWlnI_e3mHb1ZN3X0130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672245.RAqtgG_BWevzynJxMnyrQ_Ckpc4hYWlnI_e3mHb1ZN3X0130_provenance.
• NP344770.RAJD4hIBzCjlW5Rm0nGgTmBiuj-T8izOLOmKlERJrFPTg130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344770.RAJD4hIBzCjlW5Rm0nGgTmBiuj-T8izOLOmKlERJrFPTg130_provenance.
• NP672240.RAM4YCM_Cfeo5Pn3tvRspDLPmZLWRwTk9dTKvsI-jHLeM130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672240.RAM4YCM_Cfeo5Pn3tvRspDLPmZLWRwTk9dTKvsI-jHLeM130_provenance.
• NP672242.RAOXhbsZ7CtoFLQGRA7uFIgB89QJm2NHHn8DkQj5ixy-M130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672242.RAOXhbsZ7CtoFLQGRA7uFIgB89QJm2NHHn8DkQj5ixy-M130_provenance.
• NP672243.RA-Z-0VosSyOTTgHexQyzYrXUKXNQZ9wfCa2vOfFOqGaI130_assertion description "[We investigated the relationship between polymorphisms in four genes, androgen receptor (AR), prostate-specific antigen (PSA), 5alpha-reductase type II (SRD5A2) and cytochrome P450c17alpha (CYP17) and PC and benign prostatic hyperplasia (BPH).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672243.RA-Z-0VosSyOTTgHexQyzYrXUKXNQZ9wfCa2vOfFOqGaI130_provenance.